OPHT Ophthotech Corporation

2.90
0  -4%
Previous Close 3.03
Open 3.02
Price To book 0.00
Market Cap 103.84M
Shares 35,808,000
Volume 597,380
Short Ratio 4.06
Av. Daily Volume 1,170,620

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 initiated 4Q 2016.
Zimura
Wet age-related macular degeneration (Wet-AMD)
Phase 3 data released December 12, 2016 - primary endpoint not met.
Fovista
Wet age-related macular degeneration (Wet-AMD)
Phase 2/3 trial initiated January 2016. Continues to enroll as of February 2017.
Zimura
Geographic atrophy

Latest News

  1. Ophthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 3, 2017
  2. Ophthotech Announces Leadership Transition Effective July 1, 2017
  3. ETFs with exposure to Ophthotech Corp. : April 19, 2017
  4. Ophthotech (OPHT) Down 2.9% Since Earnings Report: Can It Rebound?
  5. ETFs with exposure to Ophthotech Corp. : March 27, 2017
  6. Ophthotech Corp. :OPHT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
  7. Ophthotech Corp. :OPHT-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
  8. OPHTHOTECH 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Ophthotech Corporation – (OPHT)
  9. EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm
  10. INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm
  11. INVESTOR COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017
  12. DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ophthotech Corporation (OPHT) & Lead Plaintiff Deadline: March 13, 2017
  13. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Ophthotech Corporation and Certain Officers – OPHT
  14. SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm
  15. OPHTHOTECH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Ophthotech Corporation – (OPHT)
  16. SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Ophthotech Corporation to Contact the Firm Before Imminent Lead Plaintiff Deadline
  17. IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ophthotech Corporation, and Encourages Investors with Losses to Contact the Firm
  18. SHAREHOLDER COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017